Background: Acute myocarditis (AM) is thought to be a rare cardiovascular complication of
COVID-19, although minimal data are available beyond case reports. We aim to report the …

Improvements in early interventions after acute myocardial infarction (AMI), notably, the
increased use of timely reperfusion therapy, have increased survival dramatically in recent …

Aims To examine the impact of COVID‐19 on acute heart failure (AHF) hospitalization rates,
clinical characteristics and management of patients admitted to a tertiary Heart Failure Unit …

Aims Admission rates for acute decompensated heart failure (HF) declined during the COVID‐19
pandemic. However, the impact of this reduction on hospital mortality is unknown. We …

Aims Cardiovascular diseases (CVDs) increase mortality risk from coronavirus infection (COVID-19).
There are also concerns that the pandemic has affected supply and demand of …

Aims The potential of remote ischaemic conditioning (RIC) to ameliorate myocardial
ischaemia-reperfusion injury (IRI) remains controversial. We aimed to analyse the pre-clinical …

Alleviating myocardial injury associated with ST elevation myocardial infarction is central to
improving the global burden of coronary heart disease. The chemokine stromal cell-derived …

Background Beta-blockers are widely used for many cardiovascular conditions; however,
their efficacy in contemporary clinical practice remains uncertain. Methods We performed a …

Aims The COVID-19 pandemic has resulted in excess mortality due to both COVID-19
directly and other conditions, including cardiovascular (CV) disease. We aimed to explore the …

Due to its poor capacity for regeneration, the heart is particularly sensitive to the loss of
contractile cardiomyocytes. The onslaught of damage caused by ischaemia and reperfusion, …